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HISTORICAL NOTES
Machado-Joseph disease in Brazil:  
from the first descriptions to the emergence 
as the most common spinocerebellar ataxia
Doença de Machado-Joseph no Brasil: das primeiras descrições até a emergência como a 
ataxia espinocerebelar mais comum
José Luiz Pedroso¹,², Pedro Braga-Neto¹, João Radvany², Orlando Graziani Povoas Barsottini¹,²
In 1972, two autosomal dominant diseases of Azorean an-
cestry in Massachussets were described. Progressive ataxia, 
nystagmus, dysarthria, distal muscle atrophy, brisk reflexes 
and ophthalmoplegia were common features of the so-called 
Machado disease1,2. Besides neurological signs described in 
the first report, extrapyramidal signs were also presented 
in the second report and started at variables ages, ranging 
from 17 to 46 year old2. In 1976, Joseph disease was described 
as a “new genetic entity” also in a family of Azorean ances-
try in California with dystonia associated to the other previ-
ously reported signs3. Through autopsy studies in two other 
patients with phenotypic variability similar to the previous 
three reports, in 1977, Romanul et al. described a family in 
Massachussets as Azorean disease and suggested that the 
three reports described until then might all represent a single 
genetic entity with variable clinical expression4. 
In 1978, Coutinho and Andrade studied 40 patients in 
15 families from the Portuguese Azores Islands, with au-
tosomal dominant inheritance ataxia syndrome, associat-
ed to ophthalmoplegia, pyramidal signs, dystonia, rigidity, 
and distal atrophy as the major clinical findings. Evidence 
also suggested that this was a single genetic disease with 
variable clinical phenotypes5. In the ensuing years, appar-
ently the same disease had been repeatedly described in 
other countries, in non-Azorean ancestry patients. In the 
late 1980’s, the eponym “Machado-Joseph disease” (MJD) 
was recommended to honor the first and the largest fami-
lies described until then. 
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ABSTRACT
Machado-Joseph disease is an autosomal dominant inherited disorder of Azorean ancestry firstly described in 1972. Since then, several 
Brazilian researchers have studied clinical and genetic issues related to the disease. Nowadays, Machado-Joseph disease is considered the 
most common spinocerebellar ataxia worldwide. Machado-Joseph disease still has no specific therapy to arrest progression, but the unclear 
pathophysiological mechanism, features related to genetic characteristics, phenotype variability, apparently global involvement of the ner-
vous system in the disease and the therapeutic challenges continue to attract investigators in the field of spinocerebellar ataxias. Brazilian 
researchers have distinguished themselves in the ongoing investigation seeking new knowledge about Machado-Joseph disease.
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RESUMO
A doença de Machado-Joseph é uma enfermidade autossômica dominante de origem açoriana primeiramente descrita em 1972. Desde en-
tão, vários pesquisadores brasileiros têm estudado as implicações clínicas e genéticas relacionadas com a doença. Atualmente, a doença de 
Machado-Joseph é considerada a ataxia espinocerebelar mais frequente em todo o mundo. Ainda não há terapia específica para interrom-
per a progressão da doença de Machado-Joseph. Mas o mecanismo fisiopatológico complexo, as características relacionadas às questões 
genéticas, a variabilidade fenotípica, o envolvimento global do sistema nervoso e os desafios terapêuticos continuam a atrair investigadores 
no campo das ataxias espinocerebelares. Pesquisadores brasileiros têm se destacado na investigação e na busca de novos conhecimentos 
sobre a doença Machado-Joseph.
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The first description of MJD in Brazil was carried out by 
Radvany et al. through the evaluation of two families6. In 
subsequent years, new reports of the disease from Brazilian 
authors began to emerge. In 1991, Teive et al. reported the 
clinical and laboratorial findings of five affected members of 
a family with MJD. In this article, the authors already point-
ed out parkinsonian features and peripheral nerve involve-
ment in the disease7. In 1993, Radvany et al. reported the larg-
est family tree described until now, from the state of Santa 
Catarina (therefore Catarina kindred), Brazil, and studied 
neuroimaging, psychiatric and neuropsychological findings. 
At that moment, the Catarina family tree contained 622 in-
dividuals, distributed in nine generations. Two hundred and 
thirty six persons were examined, and of these 37 were found 
by two examiners to have the disease8. 
An attempt was made to define the chromosomal 
abnormality of this family at the University of Montreal, 
but the identification of the gene defect on the long arm 
of chromosome 14 came from Japan in 19939. In 1994, 
Kawaguchi et al. showed that an expansion of a CAG re-
peat at the MJD1 or ATXN3 gene was present in all affect-
ed individuals from the study of multiple small affected 
families along the south-north commercial road from the 
port of Niigata which had been used by the Portuguese10. 
Genetic testing then confirmed the presence of this genet-
ic abnormality in the previous families diagnosed as MJD 
with or without known Portuguese ancestry.
Aiming to verify the proportion of Brazilian families with 
different mutations causing spinocerebellar ataxia (SCA), 
in 1997, Lopes-Cendes et al. investigated the frequency of 
SCA1, SCA2, MJD and DRPLA mutations in 328 Brazilian pa-
tients with SCA, belonging to 90 unrelated families with vari-
ous patterns of inheritance and originating in different geo-
graphic regions of Brazil. The MJD mutation was the most 
common, and it was detected in 30% of all patients11. In the 
following year, Iughetti et al. evaluated 38 affected and 155 
clinically normal individuals, and found that 68% of the SCA 
cases in this sample had an expanded trinucleotide repeat for 
MJD12. Nowadays, MJD is worldwide recognized as the most 
common autosomal dominant spinocerebellar ataxia. 
Phenotypic variability had often been reported before 
genetic testing in several diseases and contributed to many 
family descriptions not classifiable today. However, the diag-
nosis of entire families known to be affected for many gen-
erations became suddenly available. The most notable case 
is the Drew family of Walworth, whose clinical profile com-
prised progressive ataxia, dysarthria, ophthalmoparesis, nys-
tagmus, eyelid retraction, pyramidal signs and extrapyrami-
dal manifestations. Members of Drew family lived in the 19th 
century and were extensively examined by renowned neurol-
ogists, such as Gowers, Collier, Turner, Ferguson and others. 
Finally, in 1995, Anita Harding found abnormal trinucleotide 
repeat expansion for MJD in members of the Drew family13. 
Since the first descriptions, MJD phenotypic variabil-
ity is a central clinical issue. According to the age of onset 
and clinical manifestations, a division in five subtypes of 
MJD has been suggested. A correlation between disease 
duration, clinical subtypes and CAG has been demon-
strated14. Some clinical data have demonstrated high in-
cidence of non-motor symptoms in MJD, which include 
cognitive impairment, psychiatry disturbances, olfactory 
dysfunction and sleep disorders, besides cramps, fatigue 
and myalgia15-18. Moreover, sporadic case reports have 
demonstrated unusual motor symptoms in MJD, such as 
stiff person syndrome, camptocormia, restless legs syn-
drome and akathisia19. 
MJD still has no specific therapy to arrest progression, 
but the unclear pathophysiological mechanism, features 
related to genetic characteristics, phenotype variability, 
apparently global involvement of the nervous system in 
the disease and the therapeutic challenges continue to at-
tract investigators in the field of spinocerebellar ataxias20. 
Brazilian researchers have distinguished themselves in the 
ongoing investigation seeking new knowledge about MJD.
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